DAPZURA Trademark

Trademark Overview

On Wednesday, March 4, 2020, a trademark application was filed for DAPZURA with the United States Patent and Trademark Office. The USPTO has given the DAPZURA trademark a serial number of 88820894. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Baxter International Inc.. The DAPZURA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, anti-infectives
dapzura

General Information

Serial Number88820894
Word MarkDAPZURA
Filing DateWednesday, March 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely, anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2022SOU EXTENSION 4 GRANTED
Friday, July 29, 2022SOU EXTENSION 4 FILED
Friday, July 29, 2022TEAS EXTENSION RECEIVED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 3 GRANTED
Tuesday, February 8, 2022SOU EXTENSION 3 FILED
Tuesday, February 8, 2022TEAS EXTENSION RECEIVED
Thursday, August 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 10, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 10, 2021SOU EXTENSION 2 FILED
Tuesday, August 10, 2021TEAS EXTENSION RECEIVED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021TEAS EXTENSION RECEIVED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 13, 2020ASSIGNED TO EXAMINER
Tuesday, March 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 7, 2020NEW APPLICATION ENTERED

Related Keywords

dapzura anti infectives namely substances preparations pharmaceutical